Trials / Terminated
TerminatedNCT02416102
Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the effect of Losartan on cigarette smoke-induced lung injury in smokers and ex-smokers with and without chronic obstructive pulmonary disease (COPD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Losartan 50 mg | 50 mg Losartan taken orally once daily for 4 consecutive weeks. |
| DRUG | Losartan 100 mg | 50 mg Losartan taken orally twice daily for 4 consecutive weeks. |
Timeline
- Start date
- 2016-03-31
- Primary completion
- 2017-04-03
- Completion
- 2017-04-03
- First posted
- 2015-04-14
- Last updated
- 2020-08-20
- Results posted
- 2020-08-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02416102. Inclusion in this directory is not an endorsement.